In this study, we design a proof-of-concept treatment strategy: intratumor injection guided by CT scanning for delivery of PD-1 or PD-L1 inhibitor plus CTLA-4 inhibitor to initiate or reinitiate a better and safer anti-tumor immune system. Here, CD274 is linked to neoplasm.